In an exciting development for healthcare innovation in the region, Tadawi Health in Dubai is on the verge of launching the Amad system, a cutting-edge platform dedicated to precision medicine and extending healthy lifespans. This dynamic initiative underscores Dubai’s commitment to becoming a global hub for personalized healthcare solutions.
Tadawi Health Group in Dubai announced that it has achieved over 90% completion of the Amad system, a comprehensive national platform for precision medicine and enhancing healthy longevity. This platform has been developed over the past two years to serve as an advanced model for the future of healthcare. Marwan Ibrahim Haji Al Nasser, Chairman and CEO of Tadawi Health Group, stated that this project aligns with Dubai’s vision for the future and reinforces the emirate’s position as a global center for precision medicine and healthy longevity.
He added that the project is being implemented through a strategic partnership among four national companies, fully owned by Emirati investors, which combine expertise in medical care, genetics, artificial intelligence, nutrition, and preventive medicine. These include Tadawi Health Group, Technogenomics, specializing in genetic testing and precision medicine technologies, Taqoon AI, focused on information technology and digital transformation, and Cosmic Doctor, which specializes in nutrition, dietary supplements, preventive medicine, and enhancing quality of life.
This national partnership stems from a shared belief that the future of healthcare does not rely on treating diseases after they occur, but rather on understanding individuals comprehensively and predicting health risks before they arise. This is achieved by integrating artificial intelligence, precision medicine, genetic data, and clinical information into a cohesive system.
Marwan Al Nasser explained that the Amad system is based on a comprehensive health journey that begins with genetic testing as the cornerstone for understanding each individual’s biological characteristics. It then integrates laboratory test results and biomarkers with lifestyle and daily data to design a personalized health, treatment, nutrition, and fitness plan for each person.
The system includes genetic nutritional analysis, pharmacogenomic testing, assessment of hereditary cancer risks, and preventive cardiac genetic testing. It also encompasses comprehensive blood testing, fitness and lifestyle assessments, medication review and optimization, personalized dietary supplement programs, continuous digital health monitoring, and complete genetic sequencing.
These elements aim to build a unique health journey for each individual, based on their genetic, biological, and clinical data, as well as their lifestyle. The introduction of the Amad system is a pioneering step toward enhancing innovation in health management and adopting a model focused on prevention and personalization.